MyCrops have developed a vision diagnostics platform that uses algorithms, AI & deep learning to remotely identify hot spots of potential plant health issues and to determine optimal plant maturity. Additional platform features provide a significant increase in the bottom line. In today’s CannaCAST IL episode, Assaf Gavish, co-founder, and CSO of MyCrops introduces the platform and its many benefits. Cultivators interested in learning more about MyCrops, as well as potential investors...

Grow Director, led by Dima Chernobilsky, Co-Founder & CEO, have simplified and automated the process of growing medical grade cannabis to enable consistent growing of your optimal growth protocol, with minimal intervention so that you can start the system and come back only when the entire growth cycle is complete. Grow Director’s platform also includes a community feature that enables home-growers to share their protocols and knowledge. Potential distributors who are cannabis insiders in...

GemmaCert, led by Guy Setton, PhD., Co-Founder & CEO, has disrupted the cannabis testing industry with a portable, user-friendly & affordable device for testing cannabis potency that provides results in under 5 minutes. GemmaCert devices have been sold in 30 countries on 6 continents – setting the standard for diagnostic on-site solutions. Guy offers us insights into the key success factors that enabled their success. Potential distributors who are cannabis insiders in their markets,...

Today we host Yaron Shoob, Founder and CEO of Elixie SL. Yaron and his team have solved the challenges of both rapid onset and high bioavailability without smoking or vaping – Elixie SL’s Personalized Sublingual Delivery System. The Elixie SL device utilizes a dynamic release mechanism in which the rate of release is determined by the individual’s personal anatomy. Potential investors or strategic partners looking to collaborate are invited to reach out to Yaron at: [email protected], Elixie...

Today we interviewed Moav Gafni, Co-founder and Business Development Manager of Cannabotech, a biopharmaceutical company with a focus on the prevention and treatment of cancer, chronic pain and inflammation using botanical elements from medicinal mushrooms and cannabinoids. Everything about Cannabotech is innovative – their wellness products, their personalization technology, their pharmaceutical formulas, and wearable medical device, and even their capital-raising strategy! Moav invites...

Today we host Dr. Kobi Buxdorf, Founder and CEO of Cannadorf. Kobi reveals to us how Cannadorf is able to sidestep all growing obstacles and manufacture cannabis in a closed biological environment to produce sterile, all-natural, full-spectrum pharma-grade cannabis, with consistently identical profiles every single time. Potential pharma companies or cannabis-based drug developers looking to collaborate are invited to reach out to Kobi at [email protected], Cannadorf...

In today’s podcast, we interview Avihu Tamir, Founder, and CEO of Kanabo Research. Kanabo has developed an innovative medical-grade vaporization device that provides metered doses at a standard of safety and quality that physicians can trust. The vaporization device uses only 100% pure extracted pharmaceutical-grade cannabis with no added carriers or additives, with formulations targeted at specific medical indications. Potential distributors, as well as research partners looking to perform...

In this episode, Clifton Flack, founder, and CEO of CiiTech, reveals a revolutionary approach to weight loss that’s not centered around appetite suppression. CiiTech is conducting research centered around Fatty Liver Disease, Obesity, and Diabetes. Once patent approval is attained, Ciitech will launch a food supplement version of their unique cannabinoid formulation, while continuing the clinical studies to complete and launch a pharma version of the treatment. Learn about their unique...

In this episode, Dr. Orna Dreazen, chairperson of Nextage Cannabis Innovations and Nextar ChemPharma Solutions tells us about breakthrough developments coming out of Nextage. Nextage has developed nanotechnology that enables the penetration of various drugs, including cannabinoids, into the blood brain barrier, exhibiting both safety and efficacy. Dr. Dreazen also describes exciting developments with some of the rare cannabinoids such as CBN. Investors, as well as potential licensing...

In our new episode, we spoke with Dr. Arnon Heyman, PhD in Plant Biotechnology and CEO of Canonic, a subsidiary of Evogene. Canonic brings new genetics to the cannabis market using a Computational Predictive Biology (CPB) platform which enables them to use Big Data and AI to reach insights within the plant genetics for specific medical indications. Arnon recommends addressing three key industry pains: genetic stability, compound yield and active compounds via the plant genetics. Canonic is a...

In today’s episode, we host David Bassa, a serial entrepreneur for the past 30 years in the fields of hi-tech and biotech, with an emphasis on cannabis-based pharma. His company, Stero Biotechs has been issued a CBD-based patent covering over 130 different indications. Stero Biotechs is currently conducting seven different research studies for 7 different indications, two of them in clinical trials (Chron’s disease and Urticaria, also known as hives). Stero Biotechs’s research combats the...

In this episode, we host Nir Peles, Founder, BOD member and VP Business Development at Cannassure Therapeutics to discuss Cannassure’s cannabis-based pharma products. Cannassure is currently developing innovative & standardized IP protected pharma products with the ‘look and feel’ of pharma products as opposed to plants. These products address topical delivery for skin indications such as psoriasis and rheumatism, fem-tech IUD targeting women’s health issues, and a standardized pill for...

In this episode, we host Prof. Hinanit Koltai of Israel’s Volcan Research Institute to discuss innovation in molecular plant science. Prof. Koltai walks us through the Volcan Institute’s molecular method for discovering the specific combinations of cannabis compounds beneficial in the treatment of medical indications such as inflammatory bowel disease, skin cancer, and colon cancer. Results of the research on skin cancer were recently published in Oncotarget...

In this episode, Iris Bincovich, CEO of Innocan Pharma shares Innocan’s collaboration with Tel Aviv University to develop a novel, revolutionary approach to treat COVID-19 by using CBD loaded Exosomes. In addition to treating COVID-19, the new drug will target additional central nervous system indications. The goal is to be ready in 2021 to conduct a licensing agreement with a large pharma company. Additionally, Iris shared that Innocan will be launching their new line of CBD topicals,...

In this episode, we focus on Cannabis and women’s health with Yotam Hod, CEO & Co-Founder of Lumir Labs, Gynica and Asana Bio Group. Yotam shares with us an exciting breakthrough in the field of endometriosis . Gynica is currently looking for global partners for licensing their evidence-based products: [email protected]

We’re excited to return to broadcasting with this episode with Nadav Gil, Partner at Deloitte Israel and leader of the Israeli Cannabis Practice. In our discussion, Nadav presents an overview of the opportunities the Israeli cannabis researchers and companies offer to the global cannabis market in 2020 and describes Israel’s leading edge in science and technology.

In this week's CANNACAST IL episode - "Innovation in Cannabis Medicine" - we speak to two start-ups. Our first guest, Prof. Nissim Garti of LDS technologies, has developed breakthrough Lyotropic Delivery Systems. Our second guest, Dr. Haleli Sharir of Cannabics Pharmaceuticals, is developing Personalized Cannabinoid Medication.

Professor Raphael Mechoulam, Israel’s world-renowned cannabis researcher, in an open discussion regarding today’s clinical research needs and challenges.

CannaCAST IL was formed to strengthen and empower the Medical Cannabis industry by providing international exposure to Israel’s technology, R&D and innovation. Meet the Podcast Moderators : Heli Dangur, Director of Global Business Development, Cann10 Narkis Tessler, CEO at TeraCann and managing partner at Blue Pesto